Anderson Harvey's Form 4 filing
HP Inc (HPQ) · filed Dec 9, 2021
- Accession no.
- 0001562180-21-007610
- Filed
- Dec 9, 2021
- Trade date
- Dec 7-9, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 7 derivative transactions. Open-market sales total $297.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anderson HarveyCIK 0001842375 | Officer (Chief Legal Officer & Sec) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | Common Stock | MOption exerciseAcquired | +38,092 | $0.00 | $0 | 38,092 | Direct | |
| Dec 7, 2021 | Common Stock | FTax withholdingDisposed | −18,890 | $37.29 | −$704,408.1 | 19,202 | Direct | |
| Dec 9, 2021 | Common Stock | SSaleDisposed | −8,268 | $36.02 | −$297,813.36 | 10,934 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | Common Stock | AGrant or awardAcquired | +34,326 | –F4 | – | 34,326 | Direct | |
| Dec 7, 2021 | Common Stock | AGrant or awardAcquired | +19,829 | –F5 | – | 19,829 | Direct | |
| Dec 7, 2021 | Common Stock | AGrant or awardAcquired | +91,162 | –F6 | – | 91,162 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseDisposed | −6,507 | –F7 | – | 12,669 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseDisposed | −15,182 | –F8 | – | 29,561 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseDisposed | −10,411 | –F9 | – | 9,756 | Direct | |
| Dec 7, 2021 | Common Stock | MOption exerciseDisposed | −5,992 | –F10 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
On 12/7/2021, the reporting person was granted 34,326 RSU, one-third of which vest annually over three years on each of 12/7/2022, 12/7/2023 and 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.
Referenced by the price of 1 transaction in Table II.
- F5
On 12/7/2021, the reporting person was granted 19,829 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/2024, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.
Referenced by the price of 1 transaction in Table II.
- F6
The performance contingent stock options granted on 12/7/2021 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions.
Referenced by the price of 1 transaction in Table II.
- F7
As previously reported, on 12/7/2020, the reporting person was granted 19,003 RSUs, 6,334 of which vested on 12/7/2021, 6,334 of which is scheduled to vest on 12/7/2022 and 6,335 of which is scheduled to vest on 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 173 vested dividend equivalent rights.
Referenced by the price of 1 transaction in Table II.
- F8
As previously reported, on 12/7/2020, the reporting person was granted 44,341 RSUs, 14,780 of which vested on 12/7/2021, 14,780 of which is scheduled to vest on 12/7/2022 and 14,781 of which is scheduled to vest on 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 402 vested dividend equivalent rights.
Referenced by the price of 1 transaction in Table II.
- F9
As previously reported, on 12/6/2019, the reporting person was granted 29,268 RSUs, 9,756 of which vested on 12/7/2020 and 12/7/2021, and 9,756 of which is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 655 vested dividend equivalent rights.
Referenced by the price of 1 transaction in Table II.
- F10
As previously reported, on 12/7/2018, the reporting person was granted 16,354 RSUs, 5,451 of which vested on each of 12/7/2019 and 12/7/2020 and 5,452 of which vested on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 540 vested dividend equivalent rights.
Referenced by the price of 1 transaction in Table II.